Seqera

Seqera (operating at seqera.io) is a bioinformatics and scientific workflow automation platform engineered for enterprise-grade data management and reproducibility in life sciences. Founded in 2018 as a spinout from the Nextflow research environment, Seqera consolidates fragmented data and diverse computing resources into a unified platform trusted by over 150 leading life science organizations, including AstraZeneca, Roche, and Johnson & Johnson. Under the hood, the platform leverages Nextflow’s open-source workflow technology, augmented with enterprise-grade orchestration, real-time monitoring, and AI-driven capabilities like Co-Scientist, which autonomously executes scientific analysis at scale. This allows researchers and lab scientists to accelerate pipeline development (up to 4x faster), reduce data delivery times by 50%, and maintain full data sovereignty and traceability throughout the research lifecycle. Backed by $55.7M in funding across three rounds, including a $26.0M Series B in May 2025, Seqera positions itself as the backbone for modern biotech and genomics workflows.